Guilhaumou, R., Benaboud, S., Bennis, Y., Dahyot-Fizelier, C., Dailly, E., Gandia, P., . . . Garnier, M. (2019). Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR). Critical care (London, England), 23(1), 104-20. https://doi.org/10.1186/s13054-019-2378-9
Chicago-Zitierstil (17. Ausg.)Guilhaumou, Romain, et al. "Optimization of the Treatment with Beta-lactam Antibiotics in Critically Ill Patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française De Pharmacologie Et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française D’Anesthésie Et Réanimation—SFAR)." Critical Care (London, England) 23, no. 1 (2019): 104-20. https://doi.org/10.1186/s13054-019-2378-9.
MLA-Zitierstil (9. Ausg.)Guilhaumou, Romain, et al. "Optimization of the Treatment with Beta-lactam Antibiotics in Critically Ill Patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française De Pharmacologie Et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française D’Anesthésie Et Réanimation—SFAR)." Critical Care (London, England), vol. 23, no. 1, 2019, pp. 104-20, https://doi.org/10.1186/s13054-019-2378-9.